About Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria
Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria is a rare disease catalogued by Orphanet (ORPHA:99646). It is associated with the IDH1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria trials.
Search ClinicalTrials.gov for "Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria" or filter by Orphanet code ORPHA:99646 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria. Updated daily.